The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers
- PMID: 6807598
- DOI: 10.1038/clpt.1982.157
The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers
Abstract
The optimal conditions for performing the caffeine CO2 breath test (CBT) were investigated in smokers and nonsmokers. Caffeine labeled with 13C or 14C in all three (1, 3, and 7) methyl groups or specifically in the 1-, 3-, or 7-methyl groups were orally administered to healthy adults and the expiration of labeled CO2 was measured for 8 or 24 hr. The absolute rate of labeled CO2 excretion from trilabeled caffeine was proportional to the dose up to 3 mg/kg in all subjects. In smokers, the rate of labeled CO2 excretion averaged twice that in nonsmokers at all doses. A correlation was observed between the 2-hr cumulative CO2 excretion from trilabeled caffeine and the apparent oral metabolic clearance rate (MCR) of caffeine (R = 0.90). Monolabeled CBTs in smokers and nonsmokers demonstrated that 80% +/- 4% of labeled CO2 expired in the breath during the first 2 hr of a trilabeled CBT was derived from the 3 position; at 6 to 8 hr equal amounts were derived from the 3 and 7 positions. Little N-demethylation was observed from the 1 position at any time during the 8-hr test. The results indicate that the 2-hr cumulative excretion of labeled CO2 could be used to accurately predict the metabolic clearance rate of caffeine is the best CBT parameter for detecting the effect of smoking on caffeine N-demethylation. The data suggest that the primary routes of caffeine metabolism are 3-N-demethylation and ring hydroxylation and confirm that caffeine metabolites are N-demethylated primarily in the 3 and 7 positions.
Similar articles
-
Maturation of caffeine N-demethylation in infancy: a study using the 13CO2 breath test.Pediatr Res. 1988 Jun;23(6):632-6. doi: 10.1203/00006450-198806000-00021. Pediatr Res. 1988. PMID: 3134644
-
Study of the demethylation of [1,3,7-Me-13C] caffeine in man using respiratory exchange measurements.Biomed Mass Spectrom. 1980 Nov;7(11-12):521-4. doi: 10.1002/bms.1200071113. Biomed Mass Spectrom. 1980. PMID: 6784785
-
Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test.Eur J Clin Pharmacol. 1981;21(1):53-9. doi: 10.1007/BF00609588. Eur J Clin Pharmacol. 1981. PMID: 6800827
-
The CO2 breath tests as monitors of the cytochrome P450 dependent mixed function monooxygenase system.Prog Clin Biol Res. 1983;135:119-45. Prog Clin Biol Res. 1983. PMID: 6420801 Review.
-
[Use of the labelling of drugs with stable isotopes in clinical pharmacology in children].Arch Fr Pediatr. 1989 Mar;46(3):223-8. Arch Fr Pediatr. 1989. PMID: 2660770 Review. French.
Cited by
-
Enhanced drug metabolism in young children with cystic fibrosis.Arch Dis Child. 1997 Sep;77(3):239-41. doi: 10.1136/adc.77.3.239. Arch Dis Child. 1997. PMID: 9370904 Free PMC article.
-
In vitro analysis of factors influencing CYP1A2 expression as potential determinants of interindividual variation.Pharmacol Res Perspect. 2017 Mar 2;5(2):e00299. doi: 10.1002/prp2.299. eCollection 2017 Apr. Pharmacol Res Perspect. 2017. PMID: 28357125 Free PMC article.
-
Alternative Sampling Strategies for Cytochrome P450 Phenotyping.Clin Pharmacokinet. 2016 Feb;55(2):169-84. doi: 10.1007/s40262-015-0306-y. Clin Pharmacokinet. 2016. PMID: 26239501 Review.
-
Biomarker measurements in a coastal fish-eating population environmentally exposed to organochlorines.Environ Health Perspect. 2005 Oct;113(10):1318-24. doi: 10.1289/ehp.7970. Environ Health Perspect. 2005. PMID: 16203240 Free PMC article.
-
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's disease.Br J Clin Pharmacol. 1998 Sep;46(3):221-8. doi: 10.1046/j.1365-2125.1998.00776.x. Br J Clin Pharmacol. 1998. PMID: 9764962 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical